Article Text

Download PDFPDF
Sleep quality with WHO Step III opioid use for cancer pain
  1. Gunnhild Jakobsen1,2,
  2. Morten Engstrøm3,4,
  3. Peter Fayers1,5,
  4. Marianne J Hjermstad6,
  5. Stein Kaasa1,7,
  6. Marianne Kloke8,
  7. Rainer Sabatowski9 and
  8. Pal Klepstad1,10,11
  1. 1 European Palliative Care Research Centre (PRC), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  2. 2 Cancer Clinic, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  3. 3 Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway
  4. 4 Department of Neurology and Clinical Neurophysiology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway
  5. 5 Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
  6. 6 European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  7. 7 Department of Oncology, Oslo University Hospital and University of Oslo, Oslo, Norway
  8. 8 Department of Palliative Medicine with Institute of Palliative Care, Kliniken Essen-Mitte, Essen, Germany
  9. 9 Comprehensive Pain Center, University Hospital ‘Carl Gustav Carus’, Dresden, Germany
  10. 10 Department of Anaesthesiology and Intensive Care Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
  11. 11 Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  1. Correspondence to Gunnhild Jakobsen, European Palliative Care Research Centre (PRC), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim 7491, Norway; gunnhild.jakobsen{at}ntnu.no

Footnotes

  • Contributors GJ, SK and PK were responsible for the conception of the study. GJ, SK, MK, RS and PK collected the data, which were analysed by GJ, PF and PK. Data were interpreted by GJ, ME, PF, MJH and PK and confirmed by all authors. All authors were involved in drafting and critically appraising the manuscript before providing final approval.

  • Funding The study was funded by The Norwegian Research Council and the European Union’s 6th framework (contract 037777). GJ has funding from The Liaison Committee for Education, Research and Innovation in Central Norway.

  • Competing interests None declared.

  • Patient consent Obtained

  • Ethics approval Regional Medical Research Ethics Committee (ref 119-03). The study was approved by ethical committees at each study centre or in each country before initialisation.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Gunnhild Jakobsen and Pål Klepstad have access to the full data set.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors GJ, SK and PK were responsible for the conception of the study. GJ, SK, MK, RS and PK collected the data, which were analysed by GJ, PF and PK. Data were interpreted by GJ, ME, PF, MJH and PK and confirmed by all authors. All authors were involved in drafting and critically appraising the manuscript before providing final approval.

  • Funding The study was funded by The Norwegian Research Council and the European Union’s 6th framework (contract 037777). GJ has funding from The Liaison Committee for Education, Research and Innovation in Central Norway.

  • Competing interests None declared.

  • Patient consent Obtained

  • Ethics approval Regional Medical Research Ethics Committee (ref 119-03). The study was approved by ethical committees at each study centre or in each country before initialisation.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Gunnhild Jakobsen and Pål Klepstad have access to the full data set.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.